Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up

被引：255

作者：

Labianca, R. ^{[1
]}

Nordlinger, B. ^{[2
]}

Beretta, G. D. ^{[3
]}

Brouquet, A. ^{[4
]}

Cervantes, A. ^{[5
]}

机构：

[1] Osped Riuniti Bergamo, Dept Med Oncol, I-24100 Bergamo, Italy

[2] Hop Ambroise Pare, Dept Digest Surg, Boulogne, France

[3] St Orsola Fatebenefratelli Hosp, Dept Med Oncol, Brescia, Italy

[4] Hop Ambroise Pare, Dept Surg, Boulogne, France

[5] Univ Valencia, INCLIVA, Dept Hematol & Med Oncol, Valencia, Spain

来源：

ANNALS OF ONCOLOGY | 2010年 / 21卷

关键词：

PHASE-III TRIAL; COLORECTAL-CANCER; COMPUTED-TOMOGRAPHY; CURATIVE RESECTION; RADICAL SURGERY; CT COLONOGRAPHY; SURVEILLANCE; SURVIVAL; RISK; FLUOROURACIL;

D O I：

10.1093/annonc/mdq168

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：v70 / v77

页数：8

共 63 条

[61]

WOLMARK N, 2005, P ASCO, V23, P16

[62] A phase III randomised trial of LV5FU2+irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802) [J].

Ychou, M. ;

Raoul, J. -L. ;

Douillard, J. -Y. ;

Gourgou-Bourgade, S. ;

Bugat, R. ;

Mineur, L. ;

Viret, F. ;

Becouarn, Y. ;

Bouche, O. ;

Gamelin, E. ;

Ducreux, M. ;

Conroy, T. ;

Seitz, J. -F. ;

Bedenne, L. ;

Kramar, A. .

ANNALS OF ONCOLOGY, 2009, 20 (04) :674-680

[63]

2007, COCHRANE DATABA 0124

← 1 2 3 4 5 6 7 →